H. E. Hinson, M.D., M.C.R. is a Professor of Clinical Neurology at UCSF and a Neurointensivist at San Francisco General Hospital. Her research focuses on high dimensional data and predictive modeling in traumatic brain injury. At the American Academy of Neurology, she chairs the Clinic Research Subcommittee and serves as a member of the Science Committee. Dr. Hinson is a member of the editorial boards of the journals Neurology, Stroke, and Neurotrauma.

 

• Professor of Autoimmune Neurology
• Head, Oxford Autoimmune Neurology Group, Research laboratory
• MRC Senior Clinical Fellow
• Honorary Consultant Neurologist
• Associate Editor @Brain

RESEARCH SUMMARY

Sarosh Irani is a clinician scientist, Professor of Autoimmune Neurology and consultant neurologist, at the University of Oxford. His group is moving to the Mayo Clinic Florida from Summer 2023 and aims to improve treatments and outcomes for patients with autoantibody-mediated diseases of the nervous system and understand the biology behind these rapidly expanding conditions.

Clinically, he runs the UK’s major clinic for autoantibody related CNS diseases. He has recognised faciobrachial dystonic seizures in association with LGI1-antibodies, the importance of early immunotherapy in these patients, and distinctive psychopathological features associated with NMDAR-antibody encephalitis. In the laboratory, he has led the discovery of LGI1- and CASPR2-antibodies, their associated HLA associations and the roles of B cells in the pathogenesis of autoimmune forms of encephalitis and neuromyelitis optica.

He was awarded the Graham-Bull Prize in Clinical Science / Goulstonian Lectureship, from the Royal College of Physicians, and awards including the NIHR BRC Senior Clinical Fellowship, International Society of Neuroimmunology Clinical Science Prize and both Wellcome Intermediate and MRC Senior Clinical Fellowships.

Associate Professor Thomas Oxley MBBS BMedSc FRACP PhD is a vascular and interventional neurologist and world expert in brain computer interfaces. He is Associate Professor and Joint Laboratory Head of the Vascular Bionics Laboratory, University of Melbourne, Australia, as well as Clinical Instructor, Attending in the Department of Neurosurgery, Mount Sinai Hospital.

Dr Oxley has performed over 1600 endovascular neurosurgical procedures, including cerebral aneurysm coiling and clot retrievals in acute stroke. Dr Oxley has published over 100 internationally peer reviewed articles in journals including JAMA Neurology, Nature Biotechnology, Nature Biomedical Engineering, New England Journal of Medicine and The Lancet.

Dr Oxley is the founding CEO of Synchron, a brain data transfer company based in Brooklyn, NY and has raised over US$145M in both private funding and  grants.  Synchron is developing the leading endovascular implantable brain computer interface, StentrodeTM, a system that aims to provide a treatment for debilitating medical illnesses and enable patients to feel empowered by reconnecting online in ways that can dramatically improve their lives. In 2022, Dr Oxley and Synchron commenced an FDA-approved clinical trial on the Stentrode motor neuroprosthesis that is paving the way towards first FDA marketing approval for an implanted brain computer interface.